DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Granules India Q1 FY27 Earnings Presentation

InvestyWise 6 hrs ago·21 Jul 2026, 7:16 am

Granules India

Granules India has released its earnings presentation for the first quarter of fiscal year 2027. The company, a prominent player in the pharmaceutical contract manufacturing space, has shared its operational performance and strategic outlook for the upcoming period.

This update is significant for investors as it provides a fresh look at the company's production volumes, order book, and financial health. It helps gauge the demand for generic APIs and the company's ability to manage costs in a competitive market.

Investors should watch the management commentary on the order pipeline and any guidance provided regarding future capacity utilization. This will be crucial to understanding the company's growth trajectory and operational efficiency in the near term.